Last updated on June 2018

Sequential Application of Yisaipu and DMARDs in Treating Mild-to-Moderate AS


Brief description of study

The drug regimes in treating ankylosing spondylitis(AS) have limitations. The tumor necrosis factor inhibitors(TNFi) was effective but expensive. Disease modifying anti-rheumatic drugs (DMARDs) were cheap but insufficient. This study proposed a sequential usage of TNFi, the Yisaipu, and DMARDs, and aims to evaluate the mid-term therapeutic effect of this new scheme in treating the mild-to-moderate AS.

Clinical Study Identifier: NCT03411798

Contact Investigators or Research Sites near you

Start Over

Weizhou Jiang, master

Nanfang Hospital
Guangzhou, China
  Connect »